{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:02:56Z","timestamp":1773802976201,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.06.041","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T20:26:43Z","timestamp":1530563203000},"page":"4927-4934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"PB","title":["Development of a human papillomavirus type 6\/11 vaccine candidate for the prevention of condyloma acuminatum"],"prefix":"10.1016","volume":"36","author":[{"given":"Yue","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.06.041_b0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1071\/SH09145","article-title":"What can surveillance of genital warts tell us?","volume":"7","author":"Fairley","year":"2010","journal-title":"Sex Health"},{"key":"10.1016\/j.vaccine.2018.06.041_b0010","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0015","doi-asserted-by":"crossref","first-page":"e0177762","DOI":"10.1371\/journal.pone.0177762","article-title":"Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland","volume":"12","author":"Ginindza","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2018.06.041_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.06.041_b0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/v9100300","article-title":"Random network models to predict the long-term impact of HPV vaccination on genital warts","volume":"9","author":"Diez-Domingo","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2018.06.041_b0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines \u2013 a review of the first decade","volume":"146","author":"Harper","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2018.06.041_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.06.041_b0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.critrevonc.2017.12.017","article-title":"The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment","volume":"122","author":"Bogani","year":"2018","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.vaccine.2018.06.041_b0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2018.06.041_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.06.041_b0055","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.06.041_b0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-Valent HPV vaccine against Infection and Intraepithelial Neoplasia in Women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.06.041_b0065","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.vaccine.2013.10.081","article-title":"HPV vaccines to prevent cervical cancer and genital warts: an update","volume":"32","author":"Dochez","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2016.03.016","article-title":"Gardasil-9: a global survey of projected efficacy","volume":"130","author":"Zhai","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2018.06.041_b0075","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/j.vaccine.2010.02.057","article-title":"Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types","volume":"28","author":"Zhang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0080","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jamaoncol.2016.6192","article-title":"Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013\u20132014","volume":"3","author":"Han","year":"2017","journal-title":"JAMA oncology."},{"key":"10.1016\/j.vaccine.2018.06.041_b0085","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1016\/j.vaccine.2012.07.045","article-title":"Do correlates of HPV vaccine initiation differ between adolescent boys and girls?","volume":"30","author":"Gilkey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1557988312438911","article-title":"Providers' attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations","volume":"6","author":"Perkins","year":"2012","journal-title":"Am J Mens Health"},{"issue":"1","key":"10.1016\/j.vaccine.2018.06.041_b0095","doi-asserted-by":"crossref","first-page":"10-","DOI":"10.1186\/1471-2407-13-10","article-title":"Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe","volume":"13","author":"R\u00e9mi","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vaccine.2018.06.041_b0100","doi-asserted-by":"crossref","first-page":"e1001147","DOI":"10.1371\/journal.pmed.1001147","article-title":"Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models","volume":"8","author":"Bogaards","year":"2011","journal-title":"Plos Med"},{"key":"10.1016\/j.vaccine.2018.06.041_b0105","doi-asserted-by":"crossref","first-page":"F157","DOI":"10.1016\/j.vaccine.2012.06.091","article-title":"Modeling preventative strategies against human papillomavirus-related disease in developed countries","volume":"30","author":"Canfell","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0110","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.vaccine.2006.05.119","article-title":"Chapter 11: HPV vaccines: commercial research & development","volume":"24","author":"Inglis","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0115","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00705-009-0484-8","article-title":"Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris","volume":"154","author":"Bazan","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.06.041_b0120","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.biotechadv.2011.09.011","article-title":"Production of recombinant proteins by yeast cells","volume":"30","author":"Celik","year":"2012","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.vaccine.2018.06.041_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-8-22","article-title":"Process development in Hansenula polymorpha and Arxula adeninivorans, a re-assessment","volume":"8","author":"St\u00f6ckmann","year":"2009","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.vaccine.2018.06.041_b0130","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1016\/j.vaccine.2011.07.071","article-title":"Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles","volume":"29","author":"Rao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0135","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1005-9040(07)60042-7","article-title":"Assembly and Immunogenicity of Human Papillomavirus Type 16 Major Capsid Protein (HPV16 L1) in Pichia pastoris","volume":"23","author":"Liu","year":"2007","journal-title":"Chem Res Chin Univ"},{"key":"10.1016\/j.vaccine.2018.06.041_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0032-9592(02)00037-7","article-title":"Production of IFN\u03b1-2a in Hansenula polymorpha","volume":"38","author":"Frank M\u00fcller","year":"2002","journal-title":"Process Biochem"},{"key":"10.1016\/j.vaccine.2018.06.041_b0145","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1126\/science.286.5442.1153","article-title":"A biochemical genomics approach for identifying genes by the activity of their products","volume":"286","author":"Martzen","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.06.041_b0150","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.biotechadv.2011.09.011","article-title":"Production of recombinant proteins by yeast cells","volume":"30","author":"Celik","year":"2012","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.vaccine.2018.06.041_b0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/v8040107","article-title":"Development of a triple-color pseudovirion-based assay to detect neutralizing antibodies against human papillomavirus","volume":"8","author":"Nie","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2018.06.041_b0160","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/JVI.78.2.751-757.2004","article-title":"Efficient intracellular assembly of papillomaviral vectors","volume":"78","author":"Buck","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.06.041_b0165","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4049\/jimmunol.1201455","article-title":"Assessment of immune interference, antagonism and diversion following human immunization with bi-allelic blood-stage malaria viral vectored vaccines and controlled malaria infection","volume":"190","author":"Elias","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.06.041_b0170","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2018.06.041_b0175","article-title":"Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope","volume":"2","author":"Toapanta","year":"2007","journal-title":"Curr Hiv Res"},{"key":"10.1016\/j.vaccine.2018.06.041_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI85446","article-title":"HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions","volume":"126","author":"Lowy","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2018.06.041_b0185","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.vaccine.2007.01.013","article-title":"Developing an HPV vaccine to prevent cervical cancer and genital warts","volume":"25","author":"Bryan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0190","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1016\/j.vaccine.2011.07.071","article-title":"Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles","volume":"29","author":"Hanumantha","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.06.041_b0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virusres.2016.04.017","article-title":"Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic","volume":"220","author":"Chen","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.06.041_b0200","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/abbs\/36.8.548","article-title":"Highly efficient and economical baculovirus expression system for preparing human papillomavirus type16 virus-like particle","volume":"36","author":"Zheng","year":"2004","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.vaccine.2018.06.041_b0205","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.nano.2012.01.007","article-title":"Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles","volume":"8","author":"Zhao","year":"2012","journal-title":"Nanomed: Nanotechnol, Biol Med"},{"key":"10.1016\/j.vaccine.2018.06.041_b0210","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/jps.20696","article-title":"Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)","volume":"95","author":"Mach","year":"2006","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.vaccine.2018.06.041_b0215","doi-asserted-by":"crossref","first-page":"053106","DOI":"10.1063\/1.3592581","article-title":"The use of dynamic light scattering and brownian microscopy to characterize protein aggregation","volume":"82","author":"Li","year":"2011","journal-title":"Rev Sci Instrum"},{"key":"10.1016\/j.vaccine.2018.06.041_b0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0006-3495(90)82513-3","article-title":"Characterization of precrystallization aggregation of canavalin by dynamic light scattering","volume":"101","author":"Kadima","year":"1990","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2018.06.041_b0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bpc.2006.11.006","article-title":"The study of amorphous aggregation of tobacco mosaic virus coat protein by dynamic light scattering","volume":"127","author":"Panyukov","year":"2007","journal-title":"Biophys Chem"},{"key":"10.1016\/j.vaccine.2018.06.041_b0230","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/jmv.23995","article-title":"Optimization and validation of a high throughput method for detecting neutralizing antibodies against human papillomavirus (HPV) based on pseudovirons","volume":"86","author":"Nie","year":"2014","journal-title":"J Med Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18308697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:26:20Z","timestamp":1759400780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18308697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":46,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18308697"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a human papillomavirus type 6\/11 vaccine candidate for the prevention of condyloma acuminatum","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}